3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and Cystic Fibrosis

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol has been researched along with Cystic Fibrosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Diamond, SL; Limberis, MP; Price, AR; Wilson, JM	1
Alton, EW; Caplen, NJ; Gao, X; Gaya, H; Geddes, DM; Huang, L; Middleton, PG	1
Colledge, WH; Cuthbert, AW; Egan, JJ; Evans, MJ; Fitzjohn, EM; Gileadi, U; Gill, DR; Goddard, CA; Gooi, HC; Hannavy, K; Higgins, CF; Huang, L; Hyde, SC; Mofford, KA; Smyth, SE; Sorgi, FL; Southern, KW; Waddell, BE; Webb, AK	1

Trials

1 trial(s) available for 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and Cystic Fibrosis

Article	Year
Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene therapy, 2000, Volume: 7, Issue:13 Topics: Adolescent; Adult; Bacterial Adhesion; Cholesterol; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Epithelium; Female; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Liposomes; Male; Nasal Mucosa; Phosphatidylethanolamines; Treatment Outcome	2000

Article

Year

Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.

Gene therapy, 2000, Volume: 7, Issue:13

Topics: Adolescent; Adult; Bacterial Adhesion; Cholesterol; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Epithelium; Female; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Immunohistochemistry; Liposomes; Male; Nasal Mucosa; Phosphatidylethanolamines; Treatment Outcome

2000

Other Studies

2 other study(ies) available for 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and Cystic Fibrosis

Article	Year
Pulmonary delivery of adenovirus vector formulated with dexamethasone-spermine facilitates homologous vector re-administration. Gene therapy, 2007, Volume: 14, Issue:22 Topics: Adenoviridae; Alkaline Phosphatase; Animals; Antibodies; Cholesterol; Cystic Fibrosis; Dexamethasone; Gene Expression; Genetic Engineering; Genetic Therapy; Genetic Vectors; Immunosuppressive Agents; Liposomes; Lung; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Phosphatidylethanolamines; Spermine; T-Lymphocytes; Time Factors	2007
Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth. The European respiratory journal, 1994, Volume: 7, Issue:3 Topics: Administration, Intranasal; Adult; Cholesterol; Cystic Fibrosis; Drug Carriers; Gene Transfer Techniques; Humans; Ion Transport; Liposomes; Lung; Male; Phosphatidylethanolamines; Pseudomonas aeruginosa; Staphylococcus aureus	1994

Article

Year

Pulmonary delivery of adenovirus vector formulated with dexamethasone-spermine facilitates homologous vector re-administration.

Gene therapy, 2007, Volume: 14, Issue:22

Topics: Adenoviridae; Alkaline Phosphatase; Animals; Antibodies; Cholesterol; Cystic Fibrosis; Dexamethasone; Gene Expression; Genetic Engineering; Genetic Therapy; Genetic Vectors; Immunosuppressive Agents; Liposomes; Lung; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Phosphatidylethanolamines; Spermine; T-Lymphocytes; Time Factors

2007

Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth.

The European respiratory journal, 1994, Volume: 7, Issue:3

Topics: Administration, Intranasal; Adult; Cholesterol; Cystic Fibrosis; Drug Carriers; Gene Transfer Techniques; Humans; Ion Transport; Liposomes; Lung; Male; Phosphatidylethanolamines; Pseudomonas aeruginosa; Staphylococcus aureus

1994